M MC2 (Mycophenolic acid delayed-release 360 mg)
Pill imprint M MC2 has been identified as Mycophenolic acid delayed-release 360 mg.
Mycophenolic acid is used in the treatment of rejection prophylaxis; dermatomyositis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M MC2
More about mycophenolic acid
- Other brands: Myfortic
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.